Cleo Diagnostics Ltd (ASX:COV)
Australia flag Australia · Delayed Price · Currency is AUD
0.3250
+0.0100 (3.17%)
At close: Sep 17, 2026

Cleo Diagnostics Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
6.226.469.370.24-
Cash & Short-Term Investments
6.226.469.370.24-
Cash Growth
-3.66%-31.07%3809.00%--
Other Receivables
0.110.070.060.03-
Receivables
0.110.070.060.03-
Prepaid Expenses
0.010.010.010.31-
Total Current Assets
6.346.559.440.58-
Property, Plant & Equipment
0.030.030.030.04-
Other Intangible Assets
0.310.360.410.46-
Total Assets
6.686.949.881.08-

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
1.290.870.270.31-
Accrued Expenses
0.160.10.050-
Short-Term Debt
---1.6-
Other Current Liabilities
0.220.130.170.1-
Total Current Liabilities
1.671.10.492.02-
Total Liabilities
1.671.10.492.02-

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
18.1713.7113.710.05-
Retained Earnings
-15.47-9.53-5.53-1.77-
Comprehensive Income & Other
2.311.661.220.78-
Shareholders' Equity
5.015.839.39-0.94-
Total Liabilities & Equity
6.686.949.881.08-

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Total Debt
---1.6-
Net Cash (Debt)
6.226.469.37-1.36-
Net Cash Growth
-3.66%-31.07%---
Net Cash Per Share
0.050.050.08-0.05-
Filing Date Shares Outstanding
137.11128.5128.544.09-
Total Common Shares Outstanding
137.11128.5128.544.09-
Working Capital
4.675.448.95-1.44-
Book Value Per Share
0.040.050.07-0.02-
Tangible Book Value
4.75.488.98-1.4-
Tangible Book Value Per Share
0.030.040.07-0.03-
Machinery
--0.040.04-